科研级 Temelimab, Anti-HERV & RSV Envelope Protein Recombinant Antibody, Research Grade Temelimab
Molecular Name
Temelimab
Size
1mg, 5mg
CAS Number
1393641-34-3
Isotype
IgG4 Kappa
Clonality
Monoclonal
Concentration
1mg/ml
Source
CHO Cells
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
HERV and MRSV envelope protein[Homo sapiens]
Background
The first Chinese-made PD-1 monoclonal antibody, developed by Suzhou Zhonghe Bio, a company of Junshi Bio, was conditionally approved by the State Drug Administration (NMPA) of China in December 2018 for the treatment of locally progressive or metastatic melanoma after failure of previous standard therapy.